Taubman Institute to appoint six new scholars in 2014

Six new Taubman Scholars -- clinician-scientists selected from among the University of Michigan Medical School faculty -- will be appointed in 2014 by the A. Alfred Taubman Medical Research Institute.

Taubman Scholar grants provide $150,000 per year for three years for these select physician researchers, who combine an active clinical practice with basic laboratory science seeking new treatments and cures for the diseases they treat.  The grants are intended to fund the "high risk, high reward" research that often is overlooked by traditional sources of financial support.  In the five years since the institute's inception, the research of Taubman Scholars and Taubman Emerging Scholars  has led to nearly three dozen human clinical trials of new drugs and therapies for diseases ranging from cancer to muscular dystrophy to ALS.

Prospective scholars must hold an M.D. degree and  have until Dec. 1 to complete the application form, which will be vetted by the institute's scientific advisory board, a panel comprised of eminent medical scientsists from outside the university.  Click here for complete details and the application form. 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists